TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats

  1. Marta Gawrys-Kopczynska
  2. Marek Konop
  3. Klaudia Maksymiuk
  4. Katarzyna Kraszewska
  5. Ladislav Derzsi
  6. Krzysztof Sozanski
  7. Robert Holyst
  8. Marta Pilz
  9. Emilia Samborowska
  10. Leszek Dobrowolski
  11. Kinga Jaworska
  12. Izabella Mogilnicka
  13. Marcin Ufnal  Is a corresponding author
  1. Medical University of Warsaw, Poland
  2. Institute of Physical Chemistry, Polish Academy of Sciences, Poland
  3. Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Poland
  4. M Mossakowski Medical Research Centre, Polish Academy of Sciences, Poland

Abstract

Trimethylamine-oxide (TMAO) is present in seafood which is considered to be beneficial for health. Deep-water animals accumulate TMAO to protect proteins, such as lactate dehydrogenase (LDH), against hydrostatic pressure stress (HPS). We hypothesized that TMAO exerts beneficial effects on the circulatory system and protects cardiac LDH exposed to HPS produced by the contracting heart. Male, Sprague-Dawley and Spontaneously-Hypertensive-Heart-Failure (SHHF) rats were treated orally with either water (control) or TMAO. In vitro, LDH with or without TMAO was exposed to HPS and was evaluated using fluorescence correlation spectroscopy. TMAO-treated rats showed higher diuresis and natriuresis, lower arterial pressure and plasma NT-proBNP. Survival in SHHF-control was 66% vs 100% in SHHF-TMAO. In vitro, exposure of LDH to HPS with or without TMAO did not affect protein structure. In conclusion, TMAO reduced mortality in SHHF, which was associated with diuretic, natriuretic and hypotensive effects. HPS and TMAO did not affect LDH protein structure.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures and tables.

Article and author information

Author details

  1. Marta Gawrys-Kopczynska

    Department of Experimental Physiology and Pathophysiology, Medical University of Warsaw, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  2. Marek Konop

    Department of Experimental Physiology and Pathophysiology, Medical University of Warsaw, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  3. Klaudia Maksymiuk

    Department of Experimental Physiology and Pathophysiology, Medical University of Warsaw, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  4. Katarzyna Kraszewska

    Department of Experimental Physiology and Pathophysiology, Medical University of Warsaw, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  5. Ladislav Derzsi

    Soft Condensed Matter, Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  6. Krzysztof Sozanski

    Soft Condensed Matter, Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  7. Robert Holyst

    Soft Condensed Matter, Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  8. Marta Pilz

    Soft Condensed Matter, Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  9. Emilia Samborowska

    Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  10. Leszek Dobrowolski

    Department of Renal and Body Fluid Physiology, M Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  11. Kinga Jaworska

    Department of Experimental Physiology and Pathophysiology, Medical University of Warsaw, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  12. Izabella Mogilnicka

    Department of Experimental Physiology and Pathophysiology, Medical University of Warsaw, Warsaw, Poland
    Competing interests
    The authors declare that no competing interests exist.
  13. Marcin Ufnal

    Department of Experimental Physiology and Pathophysiology, Medical University of Warsaw, Warsaw, Poland
    For correspondence
    mufnal@wum.edu.pl
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0088-8284

Funding

Narodowe Centrum Nauki (2018/31/B/NZ5/00038.)

  • Marcin Ufnal

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The study was performed according to Directive 2010/63 EU on the protection of animals used for scientific purposes and approved by the Local Bioethical Committee in Warsaw (permission:100/2016 and 098/2019).

Copyright

© 2020, Gawrys-Kopczynska et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,559
    views
  • 283
    downloads
  • 41
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marta Gawrys-Kopczynska
  2. Marek Konop
  3. Klaudia Maksymiuk
  4. Katarzyna Kraszewska
  5. Ladislav Derzsi
  6. Krzysztof Sozanski
  7. Robert Holyst
  8. Marta Pilz
  9. Emilia Samborowska
  10. Leszek Dobrowolski
  11. Kinga Jaworska
  12. Izabella Mogilnicka
  13. Marcin Ufnal
(2020)
TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats
eLife 9:e57028.
https://doi.org/10.7554/eLife.57028

Share this article

https://doi.org/10.7554/eLife.57028

Further reading

    1. Medicine
    Yanling Huang, Haocong Mo ... Geyang Xu
    Research Article

    Glucagon-like peptide 1 (GLP-1) is a gut-derived hormone secreted by intestinal L cells and vital for postprandial glycemic control. As open-type enteroendocrine cells, whether L cells can sense mechanical stimuli caused by chyme and thus regulate GLP-1 synthesis and secretion is unexplored. Molecular biology techniques revealed the expression of Piezo1 in intestinal L cells. Its level varied in different energy status and correlates with blood glucose and GLP-1 levels. Mice with L cell-specific loss of Piezo1 (Piezo1 IntL-CKO) exhibited impaired glucose tolerance, increased body weight, reduced GLP-1 production and decreased CaMKKβ/CaMKIV-mTORC1 signaling pathway under normal chow diet or high-fat diet. Activation of the intestinal Piezo1 by its agonist Yoda1 or intestinal bead implantation increased the synthesis and secretion of GLP-1, thus alleviated glucose intolerance in diet-induced-diabetic mice. Overexpression of Piezo1, Yoda1 treatment or stretching stimulated GLP-1 production and CaMKKβ/CaMKIV-mTORC1 signaling pathway, which could be abolished by knockdown or blockage of Piezo1 in primary cultured mouse L cells and STC-1 cells. These experimental results suggest a previously unknown regulatory mechanism for GLP-1 production in L cells, which could offer new insights into diabetes treatments.

    1. Medicine
    Pinanong Na-Phatthalung, Shumin Sun ... Fudi Wang
    Research Article

    The zinc transporter Slc30a1 plays an essential role in maintaining cellular zinc homeostasis. Despite this, its functional role in macrophages remains largely unknown. Here, we examine the function of Slc30a1 in host defense using mice models infected with an attenuated stain of Salmonella enterica Typhimurium and primary macrophages infected with the attenuated Salmonella. Bulk transcriptome sequencing in primary macrophages identifies Slc30a1 as a candidate in response to Salmonella infection. Whole-mount immunofluorescence and confocal microscopy imaging of primary macrophage and spleen from Salmonella-infected Slc30a1flag-EGFP mice demonstrate Slc30a1 expression is increased in infected macrophages with localization at the plasma membrane and in the cytosol. Lyz2-Cre-driven Slc30a1 conditional knockout mice (Slc30a1fl/fl;Lyz2-Cre) exhibit increased susceptibility to Salmonella infection compared to control littermates. We demonstrate that Slc30a1-deficient macrophages are defective in intracellular killing, which correlated with reduced activation of nuclear factor kappa B and reduction in nitric oxide (NO) production. Notably, the model exhibits intracellular zinc accumulation, demonstrating that Slc30a1 is required for zinc export. We thus conclude that zinc export enables the efficient NO-mediated antibacterial activity of macrophages to control invading Salmonella.